NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the ...

A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) vaccine, Arexvy, for all adults above the age of 18, paving the way for broader ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...

The global respiratory syncytial virus vaccines market size was calculated at USD 3.55 billion in 2024 and is expected to grow steadily from USD 5.05 billion in 2025 to reach around USD 120.86 billion ...